Androgen receptor
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
|
WikiDoc Resources for Androgen receptor | |
|
Articles | |
|---|---|
|
Most recent articles on Androgen receptor Most cited articles on Androgen receptor | |
|
Media | |
|
Powerpoint slides on Androgen receptor | |
|
Evidence Based Medicine | |
|
Cochrane Collaboration on Androgen receptor | |
|
Clinical Trials | |
|
Ongoing Trials on Androgen receptor at Clinical Trials.gov Trial results on Androgen receptor Clinical Trials on Androgen receptor at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Androgen receptor NICE Guidance on Androgen receptor
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Androgen receptor Discussion groups on Androgen receptor Patient Handouts on Androgen receptor Directions to Hospitals Treating Androgen receptor Risk calculators and risk factors for Androgen receptor
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Androgen receptor | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
The androgen receptor (AR), also known as NR3C4 (nuclear receptor subfamily 3, group C, member 4), is a type of nuclear receptor which is activated by binding of either of the androgenic hormones testosterone or dihydrotestosterone.[1] The main function of the androgen receptor is as a DNA binding transcription factor which regulates gene expression.[1] However the androgen receptor also has additional functions independent of DNA binding[1]
The androgen receptor is most closely related to the progesterone receptor, and progestins in higher dosages can block the androgen receptor.
Structure
Two isoforms of the androgen receptor (A and B) have been identified:[1]
- AR-A - 87 kDa - N-terminus truncated (lacks the first 187 amino acids)
- AR-B - 110 kDa - full length
Domains
Like other nuclear receptors, the androgen receptor is modular in structure and is comprised of the following functional domains labeled A through F:
- A/B) - N-terminal regulatory domain contains:[1]
- activation function 1 (AF-1) between residues 101 and 370 required for full ligand activated transcriptional activity
- activation function 5 (AF-5) between residues 360-485 is responsible for the constitutively activity (activity without bound ligand)
- dimerization surface involving residues 1-36 (containing the FXXLF motif where F = phenylalanine, L = leucine, and X = any amino acid residue) and 370-494 which both interact with the LBD in an unusual (for a nuclear receptor) head-to-tail interaction[1][1][1]
- C) - DNA binding domain (DBD)
- D) - Hinge region - flexible region that connects the DBD with the LBD; influences subcellular trafficking
- E) - Ligand binding domain (LBD) containing
- activation function 2 (AF-2), responsible for agonist induced activity (activity in the presence of bound agonist)
- AF-2 binds both coactivator proteins (containing the LXXLL motif) and/or the AF-1 region of another molecule of androgen receptor (containing the FXXLF motif) to form a head-to-tail dimer[1]
- F) - C-terminal domain
Gene
The AR gene for the androgen receptor is located on the X chromosome at Xq11-12.
Function
Genomic
In some cell types testosterone interacts directly with androgen receptors while in others testosterone is converted by 5-alpha-reductase to dihydrotestosterone, an even more potent agonist for androgen receptor activation. Testosterone appears to be the primary androgen receptor activating hormone in the Wolffian duct while dihydrotestosterone is the main androgenic hormone in the urogenital sinus, urogenital tubercle, and hair follicles.
The primary mechanism of action for androgen receptors is direct regulation of gene transcription. The binding of an androgen to the androgen receptor results in a conformational change in the receptor which in turn causes dissociation of heat shock proteins, dimerization, and transport from the cytosol to the cell nucleus where the androgen receptor dimer binds to a specific sequence of DNA known as a hormone response element. Androgen receptors interact with other proteins in the nucleus resulting in up or down regulation of specific gene transcription. Up-regulation or activation of transcription results in increased synthesis of messenger RNA which in turn is transcribed by ribosomes to produce specific proteins. One of the known target genes of androgen receptor activation is insulin-like growth factor I (IGF-1). Thus, changes in levels of specific proteins in cells is one way that androgen receptors control cell behavior.
Androgens cause slow epiphysis, or maturation of the bones, but more of the potent epiphysis effect comes from the estrogen produced by aromatization of androgens. Steroid users of teen age may find that their growth had been stunted by androgen and/or estrogen excess. People with too little sex hormones can be short during puberty but end up taller as adults as in androgen insensitivity syndrome or estrogen insensitivity syndrome.
Non-genomic
More recently, androgen receptors have been shown to have a second mode of action. As has been also found for other steroid hormone receptors such as estrogen receptors, androgen receptors can have actions that are independent of their interactions with DNA.[1][1] Androgen receptors interact with certain signal transduction proteins in the cytoplasm. Androgen binding to cytoplasmic androgen receptors can cause rapid changes in cell function independent of changes in gene transcription, such as changes in ion transport. Regulation of signal transduction pathways by cytoplasmic androgen receptors can indirectly lead to changes in gene transcription, for example, by leading to phosphorylation of other transcription factors.
One function of androgen receptor that is independent of direct binding to its target DNA sequence, is facilitated by recruitment via other DNA binding proteins. One example is Serum Response Factor, a protein which activates several genes that cause muscle growth.[1]
AR deficiencies
The androgen insensitivity syndrome, formerly known as testicular feminization, is caused by a mutation of the Androgen Receptor gene located on the X chromosome (locus:Xq11-Xq12). The androgen receptor seems to affect neuron physiology and is defective in Kennedy disease.
References
See also
External links
- MeSH Androgen+Receptors
- Androgen receptor gene database
- Androgen physiology: receptor and metabolic disorders
- Molecular Mechanisms of Androgen Receptor Interactions
Transcription factors and intracellular receptors | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (1) Basic domains |
| ||||||||||||
| (2) Zinc finger DNA-binding domains |
| ||||||||||||
| (3) Helix-turn-helix domains |
| ||||||||||||
| (4) β-Scaffold factors with minor groove contacts |
| ||||||||||||
| (0) Other transcription factors |
| ||||||||||||
Sex hormones and related agents (primarily G03, also L02, H01C) - human endogenous in CAPS | |
|---|---|
| Progestogens: (receptor) | PROGESTERONE,Dienogest, Desogestrel, Drospirenone, Dydrogesterone, Ethisterone, Etonogestrel, Ethynodiol diacetate, Gestodene, Gestonorone, Levonorgestrel, Lynestrenol, Medroxyprogesterone, Megestrol, Norelgestromin,
Norethisterone, Norethynodrel, Norgestimate, Norgestrel, Norgestrienone, Tibolone Selective progesterone receptor modulator: Asoprisnil, CDB-4124 Antiprogestogen: Mifepristone |
| Androgens: (receptor) | TESTOSTERONE, Androstanolone, Fluoxymesterone, Mesterolone, Methyltestosterone, (see also anabolic steroids) Antiandrogens: Bicalutamide, Cyproterone, Dienogest, Flutamide, Nilutamide, Spironolactone |
| Estrogens: (receptor) | ESTRADIOL, ESTRIOL, ESTRONE, Chlorotrianisene, Dienestrol, Diethylstilbestrol, Ethinylestradiol, Fosfestrol, Mestranol, Polyestradiol phosphate Selective estrogen receptor modulator: Afimoxifene, Arzoxifene, Bazedoxifene, Clomifene, Fulvestrant, Lasofoxifene, Raloxifene, Tamoxifen, Toremifene Aromatase inhibitor: Aminogluthetimide, Anastrozole, Atamestane, Exemestane, Formestane, Letrozole, Vorozole |
| Gonadotropins: (FSHR/LHCGR) | ovulation stim.: Clomifene, Urofollitropin Antigonadotropins: Danazol, Gestrinone |
| GnRH: (receptor) | agonist: Buserelin, Goserelin, Histrelin, Leuprorelin, Nafarelin, Triptorelin antagonist: Abarelix, Cetrorelix, Ganirelix |
WikiDoc Research Resources for Androgen receptor (Click show to right to view) | |
|---|---|
| Articles on Androgen receptor | Most recent articles on Androgen receptor • Most cited articles on Androgen receptor • Review articles on Androgen receptor • Articles on Androgen receptor in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Androgen receptor | Powerpoint slides on Androgen receptor • Images of Androgen receptor • Photos of Androgen receptor • Podcasts & MP3s on Androgen receptor • Videos on Androgen receptor |
| Evidence Based Medicine Regarding Androgen receptor | Cochrane Collaboration on Androgen receptor • Bandolier on Androgen receptor • TRIP on Androgen receptor |
| Cost Effectiveness of Androgen receptor | Cost Effectiveness of Androgen receptor |
| Clinical Trials Involving Androgen receptor | Ongoing Trials on Androgen receptor at Clinical Trials.gov • Trial results on Androgen receptor • Clinical Trials on Androgen receptor at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Androgen receptor | US National Guidelines Clearinghouse on Androgen receptor • NICE Guidance on Androgen receptor • NHS PRODIGY Guidance • FDA on Androgen receptor • CDC on Androgen receptor |
| Textbook Information on Androgen receptor | Books and Textbook Information on Androgen receptor |
| Pharmacology Resources on Androgen receptor | Dosing of Androgen receptor • Drug interactions with Androgen receptor • Side effects of Androgen receptor • Allergic reactions to Androgen receptor • Overdose information on Androgen receptor • Carcinogenicity information on Androgen receptor • Androgen receptor in pregnancy • Pharmacokinetics of Androgen receptor • |
| Genetics, Pharmacogenomics, and Proteinomics of Androgen receptor | Genetics of Androgen receptor • Pharmacogenomics of Androgen receptor • Proteomics of Androgen receptor |
| Newstories on Androgen receptor | Androgen receptor in the news • Be alerted to news on Androgen receptor • News trends on Androgen receptor |
| Commentary on Androgen receptor | Blogs on Androgen receptor |
| Patient Resources on Androgen receptor | Patient resources on Androgen receptor • Discussion groups on Androgen receptor • Patient Handouts on Androgen receptor • Directions to Hospitals Treating Androgen receptor • Risk calculators and risk factors for Androgen receptor |
| Healthcare Provider Resources on Androgen receptor | Symptoms of Androgen receptor • Causes & Risk Factors for Androgen receptor • Diagnostic studies for Androgen receptor • Treatment of Androgen receptor |
| Continuing Medical Education (CME) Programs on Androgen receptor | CME Programs on Androgen receptor |
| International Resources on Androgen receptor | Androgen receptor en Espanol • Androgen receptor en Francais |
| Business Resources on Androgen receptor | Androgen receptor in the Marketplace • Patents on Androgen receptor |
| Informatics Resources on Androgen receptor | List of terms related to Androgen receptor |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .